Table 1.
Baseline characteristics | |
---|---|
Median age, years (range, IQR) | 66 (43–79, 61–70) |
Leucocytes, ×109 cells/L (range, IQR) | 94.6 (11–374, 49.3–149) |
Creatinine clearance, ml/min (median, range, IQR) | 72.5 (32.5–141.7, 61.5–91.6) |
Risk factors | |
Rai stage III/IV | 22/44 (50%) |
B symptoms | 17/45 (38%) |
FISH cytogenetic (highest risk) | |
Del(13q) | 19/45 (42%) |
Trisomy 12 | 7/45 (16%) |
Del(11q) | 10/45 (22%) |
Del(17p) | 3/45 (7%) |
No cytogenetic abnormalities | 6/45 (13%) |
Gene mutations | |
ATM | 20/42 (48%) |
BIRC3 | 2/42 (5%) |
NFKBIE | 6/42 (14%) |
NOTCH1 | 13/42 (31%) |
SF3B1 | 4/42 (9%) |
TP53 | 3/42 (7%) |
ZNF292 | 7/42 (16%) |
Unmutated IgVH | 21/38 (55%) |
β2 microglobulin ≥ 3.9 mg/L | 28/44 (64%) |